DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Gaboxadol is an investigational drug.
There have been 20 clinical trials for Gaboxadol. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2004.
The most common disease conditions in clinical trials are Sleep Initiation and Maintenance Disorders, Syndrome, and Angelman Syndrome. The leading clinical trial sponsors are H. Lundbeck A/S, Ovid Therapeutics Inc., and [disabled in preview].
Recent Clinical Trials for Gaboxadol
|A Phase 3 Study of OV101 in Pediatric Individuals With Angelman Syndrome (AS)||Ovid Therapeutics Inc.||Phase 3|
|An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome||Ovid Therapeutics Inc.||Phase 2|
|A Study of OV101 in Individuals With Fragile X Syndrome||Ovid Therapeutics Inc.||Phase 2|